Brief: Otofarma Sees In 2028 EBITDA Between €2.8-3.2 Mln
13/10/2026 07:41
BRIEF-Otofarma Sees In 2028 EBITDA Between €2.8-3.2 Mln Oct 13 (Reuters) - Otofarma SpA OTO.MI:
BOARD OF DIRECTORS APPROVES STRATEGIC GUIDELINES OF 2026-2028 BUSINESS PLAN
SEES IN 2028 REVENUES BETWEEN €28.5-31.0 MLN
SEES IN 2028 EBITDA BETWEEN €2.8-3.2 MLN
SEES IN 2028 EBITDA MARGIN BETWEEN 9.8% AND 10.3%
SEES INVESTMENTS FOR OVERALL €6.3 MLN OVER PLAN HORIZON
SEES NET CASH AT END OF 2028 BETWEEN €1.2-1.4 MLN
Further company coverage: OTO.MI
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))